Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (701,259)	$ (2,654,898)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	127,143	176,034
Stock-based compensation expense	286,909	513,824
Provision for doubtful accounts		23,305
Changes in assets and liabilities:
(Increase) in accounts receivable	(64,228)	(424,338)
(Increase) in other current assets	(192,103)	(181,406)
Decrease in other assets		1,964
Increase in accounts payable and accrued expenses	361,395	490,696
(Decrease) in deferred revenue	(128,779)	(34,868)
Net cash used in operating activities	(310,922)	(2,089,687)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of software license	(400,000)
Capital expenditures	(36,520)	(16,539)
Collection of note receivable	29,017	31,432
Net cash (used in) provided by investing activities	(407,503)	14,893
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from issuance of common stock	10,569,467
Loan proceeds on unsecured promissory note	806,100
Net proceeds from issuance of common stock from exercise of stock options	168,608	63,250
Proceeds from issuance of common stock from exercise of warrants	111,650	392,854
Withholding taxes paid on exercise of stock options and vesting of restricted stock units	(1,475,931)
Net cash provided by financing activities	10,179,894	456,104
Net increase (decrease) in cash	9,461,469	(1,618,690)
CASH, beginning of period	3,350,853	4,376,017
CASH, end of period	12,812,322	2,757,327
Supplemental disclosure of noncash investing and financing activities:
Settlement of executive bonuses with restricted stock units	$ 84,710